280771-97-3

Basic information

• Product Name: 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI)
• Synonyms: 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI);1-isopropylpiperidine-4-carboxylic acid(SALTDATA: HCl);1-isopropylpiperidine-4-carboxylic acid 1HCl;1-(propan-2-yl)piperidine-4-carboxylic acid;1-(1-Methylethyl)-4-piperidinecarboxylic acid;1-isopropyl-4-piperidin-1-iumcarboxylate;1-isopropylpiperidin-1-ium-4-carboxylate;1-propan-2-ylpiperidin-1-ium-4-carboxylate
• CAS NO: 280771-97-3
• Molecular Formula: C₉H₁₇NO₂
• Molecular Weight: 170.25
• Product Categories: ISOPROPYL
• Mol File: 280771-97-3.mol
• Article Data: 7

Chemical Properties

• Boiling Point: 272℃
• Flash Point: 118℃
• Appearance: /
• Density: 1.057
• Vapor Pressure: 0.00179mmHg at 25°C
• Refractive Index: 1.487
• PKA: 4.04±0.20(Predicted)
• CAS DataBase Reference: 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI)(280771-97-3)
• EPA Substance Registry System: 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI)(280771-97-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 280771-97-3(Hazardous Substances Data)

Usage

General Description

4-Piperidinecarboxylic acid, 1-(1-methylethyl)-(9CI) is a chemical compound with the molecular formula C9H17NO2. It is also known as Isobucic acid or 1-isobutylpiperidine-4-carboxylic acid. 4-Piperidinecarboxylicacid,1-(1-methylethyl)-(9CI) is a piperidine derivative and contains a carboxylic acid group and an isobutyl group. It has been used in the synthesis of pharmaceutical compounds and may have potential applications in the pharmaceutical industry. It is important to handle and use this chemical with caution, following proper safety protocols due to its potential hazards.

InChI:InChI=1/C9H17NO2/c1-7(2)10-5-3-8(4-6-10)9(11)12/h7-8H,3-6H2,1-2H3,(H,11,12)

Upstream product

• 154348-17-1 ethyl 1-isopropylpiperidine-4-carboxylate 

Downstream Products

• 432029-33-9 4'-bromo-2'-[(5-chloro-2-pyridyl)carbamoyl]-6'-hydroxyl-1-isopropylpiperidine-4-carboxanilide hydrochloride 
• 432029-31-7 4'-chloro-2'-[(5-chloro-2-pyridyl)carbamoyl]-6'-hydroxyl-1-isopropylpiperidine-4-carboxanilide hydrochloride 
• 432029-41-9 4'-bromo-2'-[(5-chloro-2-pyridyl)carbamoyl]-6'-hydroxy-1-methanesulfonylpiperidine-4-carboxanilide 
• 432029-34-0 4'-bromo-2'-[(5-chloro-2-pyridyl)carbamoyl]-6'-hydroxyl-1-isopropylpiperidine-4-carboxanilide 
• 280771-45-1 N-(5-Chloropyridin-2-yl)-2-[(1-isopropylpiperidin-4-ylcarbonyl)amino]-4-methoxycarbonylbenzamide 
• 280771-57-5 5-Chloro-N-(5-chloropyridin-2-yl)-2-[(1-isopropylpiperidin-4-ylcarbonyl)amino]benzamide 
• 850713-48-3 N-{4-[4-(methylamino)3-nitrophenoxy](2-pyridyl)}-[1-(methylethyl)(4-piperidyl)]carboxamide 

Relevant articles and documents

Generic JAKs inhibitor and application thereof

The invention discloses a generic JAKs inhibitor, and also discloses a composition, a preparation method and medical application of the generic JAKs inhibitor. The definition of each group in the formula is consistent with the specification.

SUBSTITUTED BENZAZOLES AND USE THEREOF AS INHIBITORS OF RAF KINASE

New substituted benzazole compounds of formula (I), compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additi

N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases

The present invention describes compounds of formula I: and enantiomers, diastereomers and pharmaceutically acceptable salts thereof. The formula I compounds are protein kinase inhibitors and are useful in the treatment of proliferative diseases, for exam